December 2019 Editor's Choice

from Listen to Gynecologic Oncology · host Health Advance

Editor's Choice: A phase II randomized, double-blind trial of a polyvalent Vaccine-KLH conjugate (NSC 748933 IND# 14384) + OPT-821 versus OPT-821 in patients with epithelial ovarian, fallopian tube, or peritoneal cancer who are in second or third complete remission: An NRG Oncology/GOG studyEditorial: Sunset, or dawn of a new age for ovarian cancer vaccine therapy?Hosted by: Dr. Barbara Goff, Deputy EditorFeaturing: Dr. O'Cearbhaill, Dr. Jazaeri, Dr. GoffCheck out more content on the journal's homepage at https://www.gynecologiconcology-online.net

Episode metadata supplied by the publisher feed · Published Dec 24, 2019

Embed this episode

Attribution link and audio player

Ready to play

December 2019 Editor's Choice

0:00 16:22

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Listen to Gynecologic Oncology?

This episode is 16 minutes long.

When was this Listen to Gynecologic Oncology episode published?

This episode was published on December 24, 2019.

Is there a transcript available for this episode?

Yes, a full transcript is available for this episode. You can read the complete transcript on the episode page.

Can I download this Listen to Gynecologic Oncology episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!